Logo image of ZOOZ

ZOOZ POWER LTD (ZOOZ) Stock Fundamental Analysis

NASDAQ:ZOOZ - Nasdaq - IL0011741845 - Common Stock - Currency: USD

1.14  +0.01 (+0.88%)

Fundamental Rating

2

Overall ZOOZ gets a fundamental rating of 2 out of 10. We evaluated ZOOZ against 94 industry peers in the Electrical Equipment industry. The financial health of ZOOZ is average, but there are quite some concerns on its profitability. ZOOZ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year ZOOZ has reported negative net income.
In the past year ZOOZ has reported a negative cash flow from operations.
ZOOZ Yearly Net Income VS EBIT VS OCF VS FCFZOOZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -10M -20M -30M -40M -50M

1.2 Ratios

ZOOZ has a Return On Assets of -102.14%. This is amonst the worse of the industry: ZOOZ underperforms 86.17% of its industry peers.
Looking at the Return On Equity, with a value of -172.91%, ZOOZ is doing worse than 70.21% of the companies in the same industry.
Industry RankSector Rank
ROA -102.14%
ROE -172.91%
ROIC N/A
ROA(3y)-85.73%
ROA(5y)N/A
ROE(3y)-137.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZOOZ Yearly ROA, ROE, ROICZOOZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 -50 -100 -150

1.3 Margins

ZOOZ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZOOZ Yearly Profit, Operating, Gross MarginsZOOZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 -500 -1K -1.5K

4

2. Health

2.1 Basic Checks

ZOOZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZOOZ has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, ZOOZ has a worse debt to assets ratio.
ZOOZ Yearly Shares OutstandingZOOZ Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 1M 2M 3M 4M 5M
ZOOZ Yearly Total Debt VS Total AssetsZOOZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -5.82, we must say that ZOOZ is in the distress zone and has some risk of bankruptcy.
ZOOZ has a Altman-Z score of -5.82. This is amonst the worse of the industry: ZOOZ underperforms 80.85% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that ZOOZ is not too dependend on debt financing.
The Debt to Equity ratio of ZOOZ (0.13) is better than 68.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z -5.82
ROIC/WACCN/A
WACC9.09%
ZOOZ Yearly LT Debt VS Equity VS FCFZOOZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M -20M 40M -40M 60M

2.3 Liquidity

ZOOZ has a Current Ratio of 3.28. This indicates that ZOOZ is financially healthy and has no problem in meeting its short term obligations.
ZOOZ has a better Current ratio (3.28) than 78.72% of its industry peers.
ZOOZ has a Quick Ratio of 2.34. This indicates that ZOOZ is financially healthy and has no problem in meeting its short term obligations.
ZOOZ has a better Quick ratio (2.34) than 77.66% of its industry peers.
Industry RankSector Rank
Current Ratio 3.28
Quick Ratio 2.34
ZOOZ Yearly Current Assets VS Current LiabilitesZOOZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 20M 40M 60M 80M

3

3. Growth

3.1 Past

The earnings per share for ZOOZ have decreased by -9.97% in the last year.
EPS 1Y (TTM)-9.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

ZOOZ is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.25% yearly.
ZOOZ is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 95.78% yearly.
EPS Next Y51.34%
EPS Next 2Y29.15%
EPS Next 3Y20.42%
EPS Next 5Y16.25%
Revenue Next Year13.99%
Revenue Next 2Y30.76%
Revenue Next 3Y71.03%
Revenue Next 5Y95.78%

3.3 Evolution

ZOOZ Yearly Revenue VS EstimatesZOOZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
ZOOZ Yearly EPS VS EstimatesZOOZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

1

4. Valuation

4.1 Price/Earnings Ratio

ZOOZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ZOOZ. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZOOZ Price Earnings VS Forward Price EarningsZOOZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZOOZ Per share dataZOOZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

ZOOZ's earnings are expected to grow with 20.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.15%
EPS Next 3Y20.42%

0

5. Dividend

5.1 Amount

ZOOZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZOOZ POWER LTD

NASDAQ:ZOOZ (6/6/2025, 8:00:02 PM)

1.14

+0.01 (+0.88%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)03-06 2025-03-06/bmo
Earnings (Next)N/A N/A
Inst Owners18.8%
Inst Owner ChangeN/A
Ins Owners3.96%
Ins Owner ChangeN/A
Market Cap13.81M
Analysts82.5
Price Target0.01 (-99.12%)
Short Float %0.74%
Short Ratio2.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.24%
PT rev (3m)-2.38%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 17.14
P/FCF N/A
P/OCF N/A
P/B 1.67
P/tB 1.67
EV/EBITDA N/A
EPS(TTM)-2.41
EYN/A
EPS(NY)-0.34
Fwd EYN/A
FCF(TTM)-1.16
FCFYN/A
OCF(TTM)-1.08
OCFYN/A
SpS0.07
BVpS0.68
TBVpS0.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -102.14%
ROE -172.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-85.73%
ROA(5y)N/A
ROE(3y)-137.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 169.5%
Cap/Sales 120.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.28
Quick Ratio 2.34
Altman-Z -5.82
F-Score3
WACC9.09%
ROIC/WACCN/A
Cap/Depr(3y)195.05%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.22%
EPS Next Y51.34%
EPS Next 2Y29.15%
EPS Next 3Y20.42%
EPS Next 5Y16.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year13.99%
Revenue Next 2Y30.76%
Revenue Next 3Y71.03%
Revenue Next 5Y95.78%
EBIT growth 1Y-25.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.73%
EBIT Next 3Y2.83%
EBIT Next 5Y8.61%
FCF growth 1Y-34.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.53%
OCF growth 3YN/A
OCF growth 5YN/A